tiprankstipranks
Trending News
More News >
Colgate-Palmolive (India) Limited (IN:COLPAL)
:COLPAL
India Market
Advertisement

Colgate-Palmolive (India) Limited (COLPAL) AI Stock Analysis

Compare
6 Followers

Top Page

IN:COLPAL

Colgate-Palmolive (India) Limited

(COLPAL)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
₹2,562.00
▲(15.24% Upside)
Colgate-Palmolive (India) Limited's strong financial performance is the most significant factor supporting its stock score. However, the high valuation and neutral technical indicators temper the overall attractiveness of the stock.

Colgate-Palmolive (India) Limited (COLPAL) vs. iShares MSCI India ETF (INDA)

Colgate-Palmolive (India) Limited Business Overview & Revenue Model

Company DescriptionColgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, oil pulling products, mouthwashes, and dental gels, as well as specialty products under the Colgate brand name. It also provides soaps, cosmetics, and toilet preparations. The company offers a range of personal care products, such as shower gels and liquid hand washes under the Palmolive brand name. It also exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India.
How the Company Makes MoneyColgate-Palmolive (India) Limited generates revenue primarily through the sale of its oral care and personal care products. The company's revenue model is centered around mass-market consumer goods, with oral care products like toothpaste and toothbrushes being the most significant contributors to its earnings. It earns money by distributing these products through a vast network of retail outlets, including supermarkets, pharmacies, and online platforms. Additionally, the company has a strong brand presence and invests in marketing and advertising to maintain its market leadership. Strategic partnerships with retailers and distributors, along with a focus on innovation and product quality, also play a crucial role in driving sales and profitability.

Colgate-Palmolive (India) Limited Financial Statement Overview

Summary
Colgate-Palmolive (India) Limited demonstrates robust financial health with strong revenue growth, high profitability margins, and minimal reliance on debt. Cash flows are solid and growing, supporting future expansion and investment.
Income Statement
85
Very Positive
Colgate-Palmolive (India) Limited shows strong performance with consistent revenue growth, evidenced by a Revenue Growth Rate of 6.33% in the latest year. The company maintains high profitability with a Gross Profit Margin of 69.89% and a Net Profit Margin of 23.78% for 2025. EBIT and EBITDA margins are robust at 48.87% and 32.42%, respectively, indicating efficient operations.
Balance Sheet
78
Positive
The balance sheet reflects solid equity strength with an Equity Ratio of 55.12% in 2025. The Debt-to-Equity Ratio is low at 0.037, indicating minimal leverage, which reduces financial risk. However, the Return on Equity is moderate at 86.31%, suggesting opportunities to enhance shareholder returns.
Cash Flow
80
Positive
The company demonstrates solid cash flow with a Free Cash Flow to Net Income Ratio of 0.92 for 2025, showing strong cash generation relative to profit. The Operating Cash Flow to Net Income Ratio is 0.97, indicating efficient conversion of profits into cash. Free Cash Flow Growth Rate is healthy at 17.78%, supporting further investment capabilities.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue60.31B60.40B56.80B52.26B50.95B48.38B
Gross Profit38.98B42.22B30.85B33.94B31.10B29.84B
EBITDA20.80B19.58B19.58B15.89B15.92B15.40B
Net Income14.37B14.37B13.24B10.47B10.78B10.35B
Balance Sheet
Total Assets30.19B30.19B31.97B28.83B29.02B28.94B
Cash, Cash Equivalents and Short-Term Investments10.95B10.95B8.89B8.06B7.24B2.97B
Total Debt608.40M608.40M717.49M689.60M830.54M911.75M
Total Liabilities13.54B13.54B13.22B11.67B11.67B17.28B
Stockholders Equity16.64B16.64B18.74B17.16B17.35B11.66B
Cash Flow
Free Cash Flow0.0013.23B11.23B11.06B15.76B7.26B
Operating Cash Flow0.0013.94B11.99B11.76B16.26B7.84B
Investing Cash Flow0.00559.70M792.39M-75.40M-1.08B713.53M
Financing Cash Flow0.00-16.71B-11.95B-10.87B-10.91B-9.56B

Colgate-Palmolive (India) Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2223.15
Price Trends
50DMA
2305.66
Negative
100DMA
2384.46
Negative
200DMA
2481.37
Negative
Market Momentum
MACD
-10.34
Positive
RSI
34.47
Neutral
STOCH
8.63
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:COLPAL, the sentiment is Negative. The current price of 2223.15 is below the 20-day moving average (MA) of 2360.91, below the 50-day MA of 2305.66, and below the 200-day MA of 2481.37, indicating a bearish trend. The MACD of -10.34 indicates Positive momentum. The RSI at 34.47 is Neutral, neither overbought nor oversold. The STOCH value of 8.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:COLPAL.

Colgate-Palmolive (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹5.90T54.6521.56%2.11%2.93%4.47%
70
Outperform
₹443.55B53.53115.17%1.97%7.85%12.60%
69
Neutral
₹604.66B43.392.29%2.12%-1.45%
66
Neutral
₹1.19T64.1615.43%1.72%5.12%
59
Neutral
₹906.35B54.1740.98%1.50%16.58%9.72%
58
Neutral
₹886.31B49.7316.37%1.60%-0.03%-5.22%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:COLPAL
Colgate-Palmolive (India) Limited
2,223.15
-1,510.74
-40.46%
IN:DABUR
Dabur India Limited
499.70
-116.25
-18.87%
IN:GODREJCP
Godrej Consumer Products Limited
1,162.70
-208.78
-15.22%
IN:HINDUNILVR
Hindustan Unilever Limited
2,510.85
-384.05
-13.27%
IN:MARICO
Marico Limited
698.30
12.47
1.82%
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
13,664.10
-2,675.39
-16.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2025